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Inconsistencies Between Physician-Reported Disclosures
at the AAOS Annual Meeting and Industry-Reported
Financial Disclosures in the Open Payments Database
Charles P. Hannon, MD, Peter N. Chalmers, MD, Matthew F. Carpiniello, MD, Gregory L. Cvetanovich, MD,
Brian J. Cole, MD, MBA, and Bernard R. Bach Jr., MD
Investigation performed at the Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois

Background: The purpose of this study was to determine the rate and type of inconsistencies between disclosures selfreported by physicians at a major academic meeting in the United States and industry-reported disclosures in the Open
Payments database for a concordant time period.
Methods: Disclosures for every ﬁrst and last author from the United States with a medical degree of a podium or poster
presentation at the 2014 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting were collected and were
compared with the disclosures reported in the Open Payments database to determine if any inconsistencies were present
and, if so, within which category.
Results: In total, 1,925 total AAOS presenters were identiﬁed, and 1,113 met the inclusion criteria. Based on
AAOS disclosures, 432 (39%) should have been listed within the Open Payments database. There were 125 presenters (11%) who reported an AAOS disclosure and thus should have been included in the Open Payments database, but were not included. An additional 259 presenters (23%) had ‡1 AAOS disclosures that were not reported
or were improperly categorized in the Open Payments database. Inconsistencies were more common for authors who
had signiﬁcantly more poster presentations (p < 0.001), podium presentations (p = 0.01), total presentations (p <
0.001), and AAOS disclosures (p < 0.001) and a signiﬁcantly higher value of payments in the Open Payments database (p < 0.001).
continued
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Conclusions: In this sample, there was a 35% rate of inconsistency between physician-reported ﬁnancial relationships for presenters at the AAOS Annual Meeting and industry-reported relationships published in the Open Payments
database.

Relationships between industry and physicians are very
common in the United States, with up to 94% of physicians
self-reporting some form of a relationship with industry1.
Physician-industry relationships can create a risk of bias in
research study designs, experimental technique, and result
interpretation and may affect treatment decisions in patient
care2-18. However, physicians are in the best position to provide
valuable innovations in design and safety that are mutually
beneﬁcial for patients, physicians, and industry1. Many safeguards exist to protect utilization of physician-developed products, including contractual elimination of royalty streams for
products used by the developer and elimination of royalty
generation by hospitals where their patients are treated. The
adequacy of conﬂict disclosure remains unclear. Certainly,
conﬂicts can be perceived to alter clinical decision-making.
There remains great interest from regulators, physician organizations, and patients in increasing transparency to mitigate
the risks associated with these ﬁnancial relationships between
physicians and industry, while continuing to allow collaboration when it produces value19-21.
The Physician Payments Sunshine Act (PPSA) was established in 2010 as part of the Affordable Care Act to improve the
transparency of physician-industry relationships in the United
States. The PPSA mandates that all drug, medical device, and
biologics companies annually report ﬁnancial payments to
physicians and teaching hospitals to the U.S. Centers for Medicare & Medicaid Services (CMS). Companies were required
to begin collecting data on August 1, 2013, and the ﬁrst set
of data was released by the CMS and was published on their
Open Payments web site on September 30, 201422. The Open
Payments database is the largest database of its kind, with
more than 12,000 orthopaedic surgeons in the database and
58,000 industry ﬁnancial payments published among them23.
Since 1985, the American Academy of Orthopaedic Surgeons
(AAOS) has required presenters at its Annual Meeting to disclose ﬁnancial conﬂicts of interest, including relationships with
industry. These relationships are also listed in the publicly available AAOS Orthopaedic Disclosure Program database. Within
this database, presenters are required to disclosure the company
and type of relationship, but not the ﬁnancial value.
The purpose of this study was to determine the rate and
type of inconsistencies between disclosures self-reported by
physicians at a major academic meeting, the 2014 AAOS Annual Meeting, and industry-reported ﬁnancial relationships
that are published in the Open Payments database for a concordant time period. Our secondary purpose was to determine
predictors of inconsistencies. We hypothesized that there would
be a high rate of inconsistencies and that having more disclosures would be predictive of having an inconsistency.

Materials and Methods
AAOS 2014 Annual Meeting Data
The AAOS 2014 Annual Meeting was held from March 11 to March 15, 2014,
in New Orleans, Louisiana. All attendees at the Annual Meeting who were
authors of presentations or course lectures, board members, or committee
members were mandated to “submit all ﬁnancial relationships with industry
occurring within the past 12 months” to the AAOS Orthopaedic Disclosure
24
Program database . All disclosures listed in the AAOS Orthopaedic Disclosure Program as of October 1, 2013, were published in the ﬁnal program of
24
the 2014 Annual Meeting . Authors were required to disclose each ﬁnancial
relationship that they have in 1 of 9 categories (Table I). Those with no
ﬁnancial disclosures were required to submit that they had no ﬁnancial
disclosures.
Basic biographical information and disclosures for every ﬁrst author
and last author of a poster or podium presentation at the 2014 Annual
Meeting were collected. Authors were categorized as podium presenter,
poster presenter, or presenter of both a podium and a poster. For each
author, academic degree, state of practice, and specialty data were collected.
The self-reported disclosure data for the authors were collected from the
Annual Meeting program according to the categories listed in Table I. The
number of disclosures within each category and the name of the company
for each disclosure were identiﬁed. If the same company was disclosed in
separate categories by the same author, each was counted as a separate
disclosure. A total number of disclosures were then calculated for each
author.

Open Payments Data
The PPSA requires that all “applicable manufacturers” of drugs, devices,
biologics, and medical supplies covered by Medicaid, Medicare, or the
Children’s Health Insurance Program (CHIP) report to CMS “payments
or other transfers of value” greater than $10 to “covered recipients.” “Covered recipients” include physicians deﬁned as a doctor of medicine or osteopathy, dentist, podiatrist, optometrist, or chiropractor who practice in
the United States. The database categorizes payments into 3 major categories: general payments, research, and ownership and investment interest.
Within general payments, payments are further subdivided into 1 of 13
categories (Table I).
The Open Payments database was accessed on December 15, 2015.
Authors of podium or poster presentations who had a medical degree and were
from the United States were included in the analysis. International presenters
and those without a medical degree were excluded as these individuals would
not be included within the Open Payments database. First authors and last
authors of poster and podium presentations who met the inclusion criteria
were identiﬁed by name in the Open Payments database. When there were
several physicians with the same name, the author who presented at the AAOS
Annual Meeting was further identiﬁed based on his or her state of practice and
his or her labeled specialty as orthopaedic surgery in the Open Payments
database.
Data collected from the Open Payments database included the total
value of general payments, the total value of research payments, the total
amount invested, and the total value of interest for a concordant time period.
For each subcategory of general payments, the name of each unique company
reporting a payment in that category was recorded, and the total number of
companies that reported a payment for that disclosure category was calculated.
The same methodology was applied to the research payments and value of the
investment and interest payment categories.
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TABLE I Corresponding AAOS and Open Payments Disclosures Categories
AAOS Disclosure Category*
Royalties
Speaker’s bureau or paid presentations

Open Payments Database Disclosure Category†
Royalty or license
1. Compensation for services other than consulting, including serving as faculty or
as a speaker at a venue other than a continuing education program
2. Compensation for serving as faculty or as a speaker for a
non-accredited and noncertiﬁed continuing education program
3. Compensation for serving as faculty or as a speaker for an accredited or certiﬁed continuing
education program
4. Honoraria

Paid consultant

Consulting fees

Other ﬁnancial or material support

1. Charitable contribution
2. Education
3. Entertainment
4. Food and beverage
5. Gift
6. Travel or lodging

*Categories excluded from the analysis were employee, unpaid consultant, stock or stock options, research or institutional support as principal
investigator, and royalties and ﬁnancial or material support from publishers. †Categories excluded from the analysis were grant, research, and
ownership and investment interest.

Comparison of Disclosures and Statistical Methods
For each individual, it was then determined whether he or she should have
been included within the Open Payments database on the basis of the presence of an AAOS disclosure under one of the following categories: royalties,
speaker’s bureau or paid presentations, paid consultant, or other ﬁnancial or
material support. These 4 AAOS categories were included in the analysis
because they directly corresponded to a disclosure category in the Open
Payments database (Table I). The AAOS disclosure categories of employee,
unpaid consultant, and publishing royalties were excluded because they did
not directly correspond to a disclosure category in the Open Payments database. Stock and research disclosures were also not included because the
CMS had previously reported that the published information in their corresponding categories of “total value of research payments,” “total amount
invested,” and “total value of interest” was incomplete as of December 15,
25
2015 .
The number of individuals who should have been included in the Open
Payments database but were excluded was then calculated. For each individual
included in the Open Payments database, his or her AAOS disclosures were
compared with the disclosures reported in the Open Payments database to
determine if any inconsistencies were present and, if so, within which category.
An inconsistency was deﬁned as when a disclosure was reported by a physician
in the AAOS Orthopaedic Disclosure Program, but was not present in the Open
Payments database. In these comparisons, the AAOS was used as the gold
standard against which the Open Payments data were judged. The number of
individuals who were inappropriately excluded from the Open Payments database was then combined with the number of individuals with inconsistencies
to determine the overall inconsistency rate.
The rate of AAOS disclosures and the inconsistency rate were then
compared between regions, between specialties, with poster presentations, with
podium presentations, with both poster and podium presentations, and with
the presence or absence of an AAOS disclosure using chi-square tests. The
number of AAOS disclosures and the value of payments reported within the
Open Payments database were then compared between those with and without
AAOS disclosures and those with and without inconsistencies using MannWhitney U tests after determining the data to be non-normally distributed

using the Kolmogorov-Smirnov test. Those variables that were signiﬁcantly
different between those with and without AAOS disclosures were then included
in a binary logistic regression analysis. A similar analysis was conducted between those with and without inconsistencies.

Results
In total, 1,925 total AAOS presenters were identiﬁed and 1,113
presenters were included in the analysis based on the exclusion
criteria (Fig. 1). Although all included had an MD, only 25

Fig. 1

Flowchart diagram demonstrating the application of inclusion and exclusion criteria.
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TABLE II Inconsistencies Between the Open Payments Database and the AAOS Disclosure Database*
Variable

AAOS Disclosure Rate

Region of the United States

P Value

Inconsistency Rate

0.410

0.249

Midwest
Northeast

41%
47%

30%
36%

South

42%

29%

West

43%

Specialty

33%
0.437

Spine

48%

0.014
39%

Foot and ankle

42%

38%

Adult reconstruction

48%

38%

Hand

44%

36%

Shoulder and elbow

45%

33%

Sports
Trauma

42%
39%

30%
25%

Tumor

34%

25%

Pediatrics

37%

21%

Practice management

36%

Presentation type

21%
<0.001

<0.001

Podium

43%

32%

Poster

38%

26%

Both

61%

51%

Author order

<0.001

First
Last

24%
66%

Both

64%

Presence of an AAOS disclosure

NA

P Value

<0.001
16%
50%
49%

NA

<0.001

No

0%

Yes

89%

*NA = not applicable.

(2%) also had a PhD and only 8 (1%) also had an MBA. Of
those included, 346 (31%) were presenting only a poster, 573
(51%) were presenting only a podium, and 194 (17%) were
presenting both. Of those included, 577 (52%) were designated
as a ﬁrst author only, 469 (42%) were designated as a last

author only, and 67 (6%) were designated as both on separate
projects.
Of those included, 488 (44%) had an AAOS disclosure
and 526 (47%) were in the Open Payments database. The distribution of disclosures in the AAOS Orthopaedic Disclosure

TABLE III Comparison of Authors with and without Inconsistencies Between the AAOS and Open Payments Databases
Variable

Without Inconsistencies*

With Inconsistencies*

Total*

P Value
<0.001

No. of poster presentations

0.5 (0.4 to 0.6)

0.8 (0.7 to 0.9)

0.6 (0.5 to 0.7)

No. of podium presentations

0.85 (0.76 to 0.93)

1.0 (0.9 to 1.1)

0.9 (0.8 to 1.1)

0.01

Total no. of presentations

1.35 (1.3 to 1.4)

1.8 (1.7 to 2.0)

1.5 (1.4 to 1.6)

<0.001

5.6 (5.1 to 6.0)

2.1 (1.7 to 2.4)

<0.001

75,340 (37,970 to 112,711)

36,423 (4,093 to 68,752)

<0.001

Total no. of AAOS disclosures
Value in Open Payments ($)

0.4 (0.2 to 0.5)
17,587 (211,828 to 47,002)

*The values are given as the mean, with the 95% conﬁdence interval in parentheses.
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Fig. 3

Fig. 2 Pie chart demonstrating the distribution of the AAOS disclosures. Fig. 3 Pie chart demonstrating the distribution of the Open Payments
disclosures.

Program is summarized in Figure 2, and the distribution of
disclosures in the Open Payments database is summarized in
Figure 3.
Inconsistencies between the Open Payments database
and the AAOS disclosures were common (Fig. 4). Based on
AAOS disclosures, 432 (39%) of those included should have
been listed within the Open Payments database, but 125 (11%)
were inappropriately not included within the Open Payments
database. There were 259 individuals (23%) listed within the
Open Payments database who had some relationships published in the AAOS Orthopaedic Disclosure Program not listed.
Overall, 384 (35%) had an inconsistency between the Open
Payments database and AAOS disclosures. Based on AAOS
disclosures, 119 (11%) had an inconsistency within royalty
relationships being disclosed, 165 (15%) had an inconsistency
within speaker’s fees, 262 (24%) had an inconsistency within
consultant fees, and 47 (4%) had an inconsistency within another ﬁnancial relationship (Fig. 3).
Table II summarizes the differences and lack thereof in
AAOS disclosure rates or inconsistency rates across regions,
orthopaedic subspecialties, presentation type, and author order. The AAOS disclosure rate (p < 0.001) and inconsistency
rate (p < 0.001) were signiﬁcantly different between podium,
poster, and combined presenters, with combined presenters
having the highest disclosure and inconsistency rates and
poster-only presenters having the lowest disclosure and inconsistency rates (Table II). The AAOS disclosure rate (p <
0.001) and inconsistency rate (p < 0.001) were signiﬁcantly
different between ﬁrst authors, last authors, and authors of
both types, with last authors having the highest disclosure and
inconsistency rates and ﬁrst authors having the lowest disclosure and inconsistency rates (Table II). Because AAOS disclosures were used as the gold standard, those with an AAOS
disclosure were also signiﬁcantly more likely to have an inconsistency (p < 0.001). Those with inconsistencies also had
signiﬁcantly more poster presentations (p < 0.001), podium
presentations (p = 0.01), total presentations (p < 0.001), and

AAOS disclosures (p < 0.001) and a signiﬁcantly higher value of
payments in the Open Payments database (p < 0.001) (Table III).
When the factors that signiﬁcantly differed between
those with and those without AAOS disclosures were compared
in a multivariable binary logistic regression model, ﬁrst-author
status, number of posters, and a higher overall value of payments within the Open Payments database were all independent predictors of AAOS disclosures (Table IV). A model
constructed with these 3 variables alone could predict 75%
of AAOS disclosures. When the factors that signiﬁcantly differed between those with and those without inconsistencies
were compared in a multivariable binary logistic regression
model, the presence of an AAOS disclosure and the number
of AAOS disclosures were independent predictors of inconsistency (Table IV). A model constructed with these 2 variables
alone could predict 91% of inconsistencies.

Fig. 4

Pie chart demonstrating the distribution of inconsistencies between the
AAOS and Open Payments databases (based on AAOS disclosures as the
gold standard).
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TABLE IV Multivariable Logistic Regression Model Statistics*
Variable

Odds Ratio†

P Value

With versus without AAOS disclosures
First author
No. of posters
Dollar value of payments in Open Payments

0.256 (0.140 to 0.467)
1.341 (1.089 to 1.652)
NA

<0.001
0.006
<0.001

With versus without inconsistencies
Presence of an AAOS disclosure
No. of AAOS disclosures

166.7 (40.00 to 1,000)
1.634 (1.438 to 1.858)

<0.001
<0.001

*NA = not applicable. †The values are given as the odds ratio, with the 95% conﬁdence interval in parentheses.

Discussion
The most signiﬁcant ﬁnding of our study is that 35% of the
physicians had an inconsistency between what ﬁnancial relationships they self-reported at the AAOS Annual Meeting and
what relationships are reported by industry and published in
the Open Payments database. When considering only those
individuals who should have been listed in the Open Payments database based on their AAOS disclosures, 89% of physicians had a relationship that they disclosed in the AAOS
Orthopaedic Disclosures Program not reported in the Open
Payments database. Of the 432 AAOS presenters who should
have been included in the Open Payments database based on
their AAOS disclosures, only 11% had their self-reported disclosures directly match what is reported in the Open Payments database.
Previous studies have published discrepancy rates as high
as 50% when comparing relationships reported by physicians
with those reported by industry9,17,26-29. Okike et al. compared
payments reported by hip and knee prosthesis manufacturers
with disclosures self-reported by physicians and found an overall inconsistency rate of 29%26. Buerba et al. reported a similar
inconsistency rate of 46% between payments reported by industry and disclosures self-reported at a national orthopaedic
meeting28. The results from the present study indicate that
those with a greater sum of payments reported in the Open
Payments database were more likely to have inconsistencies.
There are likely several contributing reasons for the high
inconsistency rate between what is self-reported by physicians
and what is published in the Open Payments database. First,
there are errors in the large, complex Open Payments database.
Prior to its initial release in September 2014, >39% of the data
were de-identiﬁed because of potential inaccuracies25. Despite a
brief period in which physicians could review and could dispute the data, only 5% of physicians took advantage of this
opportunity30. It is unknown how many physicians were aware
of the opportunity as it was not well publicized and the review
period was short at 45 days25,31. Second, there are many companies, such as private groups in development, that are not
covered by CMS or CHIP and thus are not required to report
to CMS. Third, the Open Payments database only reports mon-

etary relationships, while the AAOS Orthopaedic Disclosure
Program also includes non-ﬁnancial conﬂicts of interests.
Fourth, inconsistencies could be related to differing rules
and deﬁnitions or to misunderstandings of what relationships
should be disclosed, which apply to disclosures by industry
and by physicians alike. Disclosure guidelines also change
often and physicians may be unaware of the change in policy.
Prior to 2007, the AAOS required physicians to only report
“relevant relationships,” and many physicians may still interpret the current AAOS disclosure policy as such. Additionally,
physicians may have differences in understandings of the reporting period of time that could have contributed to the discrepancies. Our ﬁndings indicate that the Open Payments
database may not provide an accurate accounting of physicianindustry relationships.
Inconsistencies were more common among spine subspecialists, authors with more presentations, last authors, and
those with a greater value of payments in the Open Payments
database. Last authors were more likely to have disclosures as
they are often the more senior author; however, we were unable
to determine whether time in practice was related to inconsistences. The presence of an AAOS disclosure and the number
of AAOS disclosures were the only 2 independent predictors
of inconsistency. These results suggest that authors with more
AAOS disclosures should be particularly attentive to the Open
Payments database as they are at increased risk for inconsistencies within their Open Payments published record.
There were several limitations to this study, most notably the difference in reporting structures between the AAOS
and Open Payments database. Unfortunately, the AAOS disclosure categories and the Open Payments database categories
are not the same. This may have led to differences in the way
that certain relationships were categorized. A second limitation was that, at the time of this study, the Open Payments
Program published payments from August 1, 2013, to December 31, 2013. The AAOS disclosure time period is at least 12
months prior to October 1, 2013. This is a recognized limitation; however, these were the best possible data to compare
at the time of this study and we believe that the effect of this
time discrepancy was not likely to be substantial. The greatest
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inconsistencies were seen with royalty payments (11%),
speaker’s fees (15%), and consultant fees (24%), all of which
are typically, but not necessarily, long-term ﬁnancial relationships. Fourth, we chose to use the AAOS disclosures as the gold
standard to compare the Open Payments database against because it has been in existence since 1985 and its completeness
has been previously studied26. We recognize that neither the
Open Payments database nor the AAOS disclosures are completely accurate representations of ﬁnancial relationships for
each physician.
The impact of the Open Payments database on the future of patients’ health-care decisions, biomedical research,
government regulators, and the relationships between physicians and industry remains to be seen, but could be substantial. Certainly, one outcome is that physicians receive less
compensation for collaborating with industry because of the
stigma that may be associated with such a relationship. Future
regulations may also limit the amount of compensation that
physicians receive for collaborating with industry. The “opportunity cost” of partnering with industry may be too high
for the physician when compared with the potential personal
and ﬁnancial beneﬁt of spending time in the clinic, in the
operating room, performing research, or with family. Transparency and accurate reporting hopefully will not discourage
fair and equitable compensation for the value added by physician collaboration. The high rate of inconsistency between
the ﬁnancial relationships listed in the Open Payments database and those reported by physicians hopefully encourages
the individual clinician to review the Open Payments database
for errors, including omissions of relationships. Physician societies, such as the AAOS, must decide whether to accept and
to publish the disclosures that physicians report, the Open
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Payments database report, or both. The high rate of inconsistency of the Open Payments database in its current form may
steer physician societies away from publishing those data at
this time.
Patients, industry, regulators, and physician societies
and organizations will have to consider whether to rely on selfreported physician ﬁnancial relationships or to transition to
the Open Payments database. As these Open Payments data
begin to be accessed, used, and publicized, all must be aware of
the 35% inaccuracy rate within the database. Continued efforts
by CMS and industry as well as further engagement of physicians with the database will hopefully improve the accuracy
of the Open Payments database over time. n
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